Leukemia: Acute myeloid leukemia, Acute lymphoblastic leukemia, Chronic myelogenous leukemia, Lymphoid leukemia, Myeloid leukemia
felixqpn | yesterday
Based on the novel "My Sister's Keeper" by Jodi Picoult. Anna is not sick, but she might as well be. By age thirteen, she has undergone countless surgeries, transfusions, and shots so that her older sister, Kate, can somehow fight the leukemia that has plagued her since childhood. The product of preimplantation genetic diagnosis, Anna was conceived as a bone marrow match for Kate - a life
VitaBeat (Free subscription) | 11/20/2009
Long-term exposure to formaldehyde used for embalming increases funeral industry workers' risk of death from myeloid leukemia, according to a new U.S. government study. Researchers in the Division of Cancer Epidemiology and Genetics at the U.S. National Cancer Institute analyzed data on funeral industry workers who died between 1960 and 1986. Information about the workers' work practices and exposure...
Medical News Today (Free subscription) | 11/20/2009
Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies' applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic...
PR News Wire (Free subscription) | 11/19/2009
MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. announced today the dosing of the first patient in a randomized Phase 2B study of AEG35156, a targeted antisense therapeutic in mid-stage development for multiple oncology indications.
Seattle Post-Intelligencer (Free subscription) | 11/18/2009
NEW YORK -- Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration is withholding a decision to expand approval of Rituxan as a leukemia treatment, pending further discussion.
Miami Herald (Free subscription) | 11/18/2009
Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration has asked for more information before considering approving Rituxan as a leukemia treatment.
San Fransisco Chronicle (Free subscription) | 11/18/2009
Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration has asked for more information before considering approving Rituxan as a leukemia treatment. The drug is already approved as a treatment for rheumatoid arthritis and... BiogenIdec - Food and Drug Administration - Genentech - Rituximab - Health
Business Wire (Free subscription) | 11/18/2009
SOUTH SAN FRANCISCO, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies’ applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment...
YA Authors Cafe (Free subscription) | 11/18/2009
She always believed he was her destiny—but what if fate has other plans? Enter the realm of The Immortals—and experience the extraordinary #1 New York Times bestselling series that has taken the world by storm. Ever and Damen have traveled through countless past lives—and fought off the world’s darkest enemies—so they could be together forever. But just as their long-awaited...
Breaking News from The Huntsville Times - al.com (Free subscription) | 11/18/2009
Hutch Mohr, a 5-year-old Monrovia boy with acute lymphoblastic leukemia, hopes to be among those participating in the annual "Give thanks. Walk."
The IN VIVO Blog (Free subscription) | 11/18/2009
Friday's announcement that bits of rubber and other detritus were found in vials of five different drugs manufactured at Genzyme's beleaguered Allston Landing plant was worthy of the satirical publication " The Onion "--except that it was true. The picture grew murkier over the weekend, with the arrival of another Form 483 missive from FDA about ongoing manufacturing issues and a complete...
Business Wire (Free subscription) | 11/18/2009
Business Wire (Free subscription) | 11/18/2009
AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc. announced today that it has entered into an exclusive agreement with Life Technologies Corporation to develop and distribute worldwide an in-vitro diagnostic test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). As part of the agreement, Asuragen will pursue CE marked-IVD registration...
Medical News Today (Free subscription) | 11/17/2009
Paul Allen who co-founded the computer giant Microsoft with Bill Gates in the 1970s has been diagnosed with Non-Hodgkin's Lymphoma, 25 years after surviving Hodgkin's lymphoma. The news was announced in a memo to the staff of Allen's company Vulcan, by CEO Jody Allen, who is also Paul Allen's sister. A copy of the memo was also sent to the media.
Pharm Aid (Free subscription) | 11/16/2009
The U.S. Preventative Services Task Force (USPSTF) of HHS’ Agency for Healthcare Research and Quality (AHRQ) has launched an all-out jihad on women. The AHRQ and USPSTF are making some pretty radical recommendations: no mammography for women over age 74, a recommendation against mammo for women age 40-49 and mammo only every other year for women age 50-74. It’s not that there isn’t...
The 3 latest articles published by users on Leukemia :
felixqpn | yesterday
Based on the novel "My Sister's Keeper" by Jodi Picoult. Anna is not sick, but she might as well be. By age thirteen, she has undergone countless surgeries, transfusions, and shots so that her older sister, Kate, can somehow fight the leukemia that has plagued her since childhood. The product of preimplantation genetic diagnosis, Anna was conceived as a bone marrow match for Kate - a life and a role
aarkstore | 10/28/2009
Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Therapy Area Pipeline Report contains detailed information on the acute lymphoblastic leukemia or leukemia or chronic lymphocytic leukemia or chronic myelogenous leukemia or acute myelogenous leukemia or hairy cell leukemia drug pipeline. This...
julieadam | 09/11/2009
The news is filled with new discoveries and benefits of stem cell therapy on a daily basis. However, as most stem cell treatments and therapies aren’t yet approved in the U.S., patients are left in a quandry when it comes to potential treatment. However, one of the most commonly performed transplants in the U.S. has been the bone marrow transplant. Since 1968, this treatment has been used to treat...
Videos